首页> 美国卫生研究院文献>Scientific Reports >Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus
【2h】

Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus

机译:在Epstein-Barr病毒感染的胃上皮细胞中通过增强子区域的动态表观遗传改变对肿瘤相关基因的调控

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epstein-Barr virus (EBV) infection is associated with tumours such as Burkitt lymphoma, nasopharyngeal carcinoma, and gastric cancer. We previously showed that EBV(+) gastric cancer presents an extremely high-methylation epigenotype and this aberrant DNA methylation causes silencing of multiple tumour suppressor genes. However, the mechanisms that drive EBV infection-mediated tumorigenesis, including other epigenomic alteration, remain unclear. We analysed epigenetic alterations induced by EBV infection especially at enhancer regions, to elucidate their contribution to tumorigenesis. We performed ChIP sequencing on H3K4me3, H3K4me1, H3K27ac, H3K27me3, and H3K9me3 in gastric epithelial cells infected or not with EBV. We showed that repressive marks were redistributed after EBV infection, resulting in aberrant enhancer activation and repression. Enhancer dysfunction led to the activation of pathways related to cancer hallmarks (e.g., resisting cell death, disrupting cellular energetics, inducing invasion, evading growth suppressors, sustaining proliferative signalling, angiogenesis, and tumour-promoting inflammation) and inactivation of tumour suppressive pathways. Deregulation of cancer-related genes in EBV-infected gastric epithelial cells was also observed in clinical EBV(+) gastric cancer specimens. Our analysis showed that epigenetic alteration associated with EBV-infection may contribute to tumorigenesis through enhancer activation and repression.
机译:爱泼斯坦-巴尔病毒(EBV)感染与Burkitt淋巴瘤,鼻咽癌和胃癌等肿瘤有关。我们以前表明,EBV(+)胃癌表现出极高的甲基化表观基因型,这种异常的DNA甲基化会导致多个肿瘤抑制基因沉默。然而,驱动EBV感染介导的肿瘤发生的机制,包括其他表观基因组改变,仍不清楚。我们分析了由EBV感染引起的表观遗传学改变,尤其是在增强子区域,以阐明它们对肿瘤发生的贡献。我们对感染或未感染EBV的胃上皮细胞中的H3K4me3,H3K4me1,H3K27ac,H3K27me3和H3K9me3进行了ChIP测序。我们表明,在EBV感染后,抑制性标记重新分布,从而导致异常的增强子激活和抑制。增强子功能障碍导致与癌症标志有关的途径被激活(例如,抵抗细胞死亡,破坏细胞能量,诱导侵袭,逃避生长抑制剂,维持增殖信号,血管生成和肿瘤促进炎症)和肿瘤抑制途径的失活。在临床EBV(+)胃癌标本中也观察到EBV感染的胃上皮细胞中癌症相关基因的失调。我们的分析表明,与EBV感染相关的表观遗传学改变可能通过增强子激活和抑制作用促进了肿瘤的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号